Supercharge Your Innovation With Domain-Expert AI Agents!

Novel thyroid receptor ligands

一种甲氧基、化合物的技术,应用在新化合物领域,能够解决效能和耐受性未知等问题

Inactive Publication Date: 2007-07-04
KARO BIO AB
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In Graves' hyperthyroidism, glucocorticoids can reduce thyroid secretion of T 4 , but efficacy and tolerability unknown

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel thyroid receptor ligands
  • Novel thyroid receptor ligands
  • Novel thyroid receptor ligands

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0079] {4,6-Dibromo-5-[3-isopropyl-4-(naphthyl-2-methoxy)phenoxy]indanyl-1}acetic acid

[0080] (a) Add sodium acetate (7.0 g, 83 mmol) to a mixture of 5-hydroxy-1-indanone (5.6 g, 38 mmol), acetic acid (260 ml) and 4-5 drops of water, then add dropwise Bromine (13.3 g, 83 mmol) in acetic acid (60 mL). The reaction mixture was stirred at room temperature for 18 hours, and the precipitate was filtered and dried. 8.4 g (72%) of 4,6-dibromo-5-hydroxy-1-indanone were obtained as a solid, which was used directly in the next experiment without further purification.

[0081] (b) In a mixture containing bis-(3-isopropyl-4-methoxyphenyl)iodonium tetrafluoroborate (6.25 g, 12.2 mmol), bronze (1.02 g) and dichloromethane (25 mL ) in a stirred suspension system containing 4,6-dibromo-5-hydroxyl-1-indanone (2.50 g, 8.17 mmol) and triethylamine (1.00 g, 8.99 mmol) in nitrogen at room temperature Dichloromethane solution (25 mL). The reaction mixture was stirred for 48 hours in the dark ...

Embodiment 2

[0087] {4,6-Dibromo-5-[4-(4-fluorobenzyloxy)-3-isopropylphenoxy]indanyl-1}acetic acid

[0088] 4-Fluorobenzyl bromide (15 mg, 0.080 mmol) and ethyl[4,6-dibromo-5-(3-isopropyl-4-hydroxyphenoxy)indanyl-1]acetate (20 mg, 0.039 mmol) was coupled and then worked up according to the procedure described in Example 1. Obtained 5.3 mg (23%) of {4,6-dibromo-5-[4-(4-fluorobenzyloxy)-3-isopropylphenoxy]indanyl-1}acetic acid. LC-MS (ES) m / z 591 (M-1).

Embodiment 3

[0090] {4,6-Dibromo-5-[3-isopropyl-4-(5-methylisoxazolyl-3-methoxy)phenoxy]indanyl-1}acetic acid ethyl[4 , 6-dibromo-5-(3-isopropyl-4-hydroxyphenoxy)indanyl-1] acetate (20 mg, 0.039 mmol), potassium carbonate (11 mg, 0.080 mmol) The mixture with acetonitrile (0.75 mL) was stirred at room temperature for 30 minutes. 3-Chloromethyl-5-methylisoxazole (10.5 mg, 0.080 mmol) and a catalytic amount of potassium iodide in acetonitrile (0.25 mL) were added, and the reaction mixture was stirred at 80°C. After 16 hours, the reaction mixture was purified on a short column (SPE-silica, 1 g / 6 mL, n-heptane / ethyl acetate 65:35), the resulting filtrate was concentrated, the residue and THF (0.50 mL) and Lithium hydroxide (0.5 mL, 1N) was stirred at room temperature for 16 hours. The reaction mixture was filtered through an SCX-column (strong cation exchanger: silane benzenesulfonate, 1 g / 3 ml, eluting with methanol), and the filtrate was concentrated. The filter residue was dissolved with ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

This invention relates to novel compounds according to the general formula: which are thyroid receptor ligands, preferably antagonists, partial antagonists or partial agonists and to methods for using such compounds in the treatment of cardiac and metabolic disorders, such as cardiac arrhythmias, thyro-toxicosis, subclinical hyperthyrodism and liver diseases.

Description

technical field [0001] The present invention relates to novel compounds which are thyroxine receptor ligands, preferably antagonists, and methods of using these compounds in the treatment of cardiac and metabolic disorders such as arrhythmias, thyrotoxicosis, subclinical hyperthyroidism and liver disease . Background technique [0002] Nuclear hormone receptors are a class of intracellular, ligand-regulated transcription factors, including thyroid hormone receptors. Thyroid hormones play an important role in mammalian growth, development and homeostasis. They regulate important genes in the gut, skeletal and cardiac muscle, liver and central nervous system, affect overall metabolic rate, cholesterol and triglyceride levels, heart rate, and influence mood and physical state. [0003] There are two major subtypes of thyroid hormone receptors, TRα and TRβ, expressed from two different genes. Distinct RNA processing results in at least two isoforms for each gene. TRα 1 , TR...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07C59/215C07D261/06C07D213/04C07D209/04C07D271/06C07D251/12C07D413/02C07D263/30A61K31/085A61K31/33A61K51/00A61P5/14A61P9/06A61P17/00A61K31/192A61K31/42A61K31/421A61K31/4245A61K31/4402A61K31/53A61K31/59A61P1/16A61P3/00A61P5/16A61P9/00A61P9/04A61P17/02A61P17/06A61P17/14A61P25/32A61P31/14A61P43/00C07C59/72C07C65/26C07D209/12C07D213/30C07D251/18C07D261/08C07D263/32C07D413/04
CPCC07D263/32C07D413/04C07D209/12C07D261/08C07D251/18C07D271/06C07D213/30A61P1/16A61P17/00A61P17/02A61P17/06A61P17/14A61P25/32A61P3/00A61P31/14A61P43/00A61P5/14A61P5/16A61P9/00A61P9/04A61P9/06C07C59/215A61K31/33A61K31/085
Inventor 马赫毛德·拉海迈格哈代姆尼拉吉·加尔格乔亨·马尔姆
Owner KARO BIO AB
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More